Posted by bassman on October 8, 2006, at 12:59:49
In reply to Re: Valdoxan, gepirone, prx00023, posted by psychobot5000 on October 8, 2006, at 10:50:39
12-15 months is really fast-I'm afraid three years isn't uncommon, esp. for psychoactive drugs. If there are anti-cancer drugs, no matter how ineffective, they'll get priority in terms of review. But it's just luck-what else is being reviewed, how happy the reviewers are that day, whether everyone has done a good job on their studies and the Feds need little more info, etc. If it is seen as a "me-too" drug, it might increase the review process, too.
I'm really amazed that better AD's haven't been developed-it would seem to be such a lucrative market and the efficacy of available meds is very lacking. Dunno.
poster:bassman
thread:692938
URL: http://www.dr-bob.org/babble/20061003/msgs/692982.html